Update in Hematology: Graft-versus-Host Disease

Update in Hematology: Graft-versus-Host Disease

David L. Porter, MD discusses the treatment algorithims in use at Penn Medicine and the Abramson Cancer Center to minimize the effects of graft-versus-host disease, one of the severe and debilitating effects of chemotherapy in patients with hematological cancers.

 

 
 

Published

August 14, 2014

Created by

Penn Physician VideoLink